miRNA expression in COVID-19

[1]  M. Radisic,et al.  Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies , 2022, eBioMedicine.

[2]  A. Bonfigli,et al.  Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality , 2022, Mechanisms of Ageing and Development.

[3]  P. Kaye,et al.  Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19 , 2021, iScience.

[4]  A. Banerjee,et al.  The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review , 2021, Virus Research.

[5]  M. Matin,et al.  Role of microRNAs in COVID-19 with implications for therapeutics , 2021, Biomedicine & Pharmacotherapy.

[6]  Larry N. Singh,et al.  Role of miR-2392 in driving SARS-CoV-2 infection , 2021, Cell Reports.

[7]  M. Srougi,et al.  MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19 , 2021, Molecular biology research communications.

[8]  A. Coppola,et al.  Role of endothelial miR-24 in COVID-19 cerebrovascular events , 2021, Critical Care.

[9]  Yun Xu,et al.  MicroRNA-28-3p inhibits angiotensin-converting enzyme 2 ectodomain shedding in 293T cells treated with the spike protein of severe acute respiratory syndrome coronavirus 2 by targeting A disintegrin and metalloproteinase 17 , 2021, International journal of molecular medicine.

[10]  Chen-Yu Zhang,et al.  Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients , 2021, Signal Transduction and Targeted Therapy.

[11]  Maria Narożna,et al.  Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy , 2021, International journal of molecular sciences.

[12]  Najwa Skafi,et al.  Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19) , 2021, Infection, Genetics and Evolution.

[13]  H. Pandya,et al.  Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3′UTR region: A computational genomics assessment , 2021, Computers in Biology and Medicine.

[14]  A. Jebali,et al.  The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness , 2021, Neurologia.

[15]  A. Jebali,et al.  The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness , 2021, Neurologia.

[16]  F. Uchiumi,et al.  Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2 , 2021, Nucleosides, nucleotides & nucleic acids.

[17]  A. Jebali,et al.  The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization , 2021, European Journal of Medical Research.

[18]  M. Clerici,et al.  MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women , 2021, Cells.

[19]  B. Pardamean,et al.  Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis , 2021, Genes & Genomics.

[20]  N. Shaik,et al.  Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection , 2021, Computers in Biology and Medicine.

[21]  M. Giacca,et al.  SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care , 2021, Nature Communications.

[22]  N. Potenza,et al.  Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation , 2021, Frontiers in Genetics.

[23]  Bilal Ahmad,et al.  SNPs at 3′UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies , 2020, Mammalian Genome.

[24]  Aydın Demiray,et al.  Serum microRNA signature is capable of predictive and prognostic factor for SARS-COV-2 virulence , 2021, Turkish Journal of Biochemistry.

[25]  C. Cava,et al.  In Silico Identification of miRNA–lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection , 2021, Cells.

[26]  Kenny Q. Ye,et al.  Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV‐CATCHER): A customizable purification assay designed for small‐RNA biomarker identification and evaluation of circulating small‐EVs , 2021, Journal of extracellular vesicles.

[27]  M. Nieto-Díaz,et al.  In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR , 2021, International journal of molecular sciences.

[28]  J. Riera,et al.  Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients , 2021, Translational Research.

[29]  M. Hołda,et al.  Further insights into the molecular complexity of the human sinus node - The role of 'novel' transcription factors and microRNAs. , 2021, Progress in biophysics and molecular biology.

[30]  Xin Hu,et al.  Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12 , 2021, Molecular Therapy.

[31]  M. Hasan,et al.  Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach , 2021, Computers in Biology and Medicine.

[32]  A. Banerjea,et al.  SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia , 2021, Frontiers in Immunology.

[33]  H. B. Baghi,et al.  Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC , 2021, International Immunopharmacology.

[34]  Wenyu Lin,et al.  Differentially expressed immune response genes in COVID-19 patients based on disease severity , 2021, Aging.

[35]  Feng-hua Chen,et al.  SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing , 2021, International journal of biological sciences.

[36]  M. Abbasifard,et al.  The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19. , 2021, Iranian journal of immunology : IJI.

[37]  S. Soltani,et al.  The role of miRNAs in COVID-19 disease , 2021, Future Virology.

[38]  J. Pezacki,et al.  MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19 , 2021, Drugs.

[39]  G. Gao,et al.  Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients , 2021, Cellular & Molecular Immunology.

[40]  Thi H. O. Nguyen,et al.  Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection , 2021, PLoS pathogens.

[41]  Salah Ayoub,et al.  Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy , 2021, iScience.

[42]  G. Santulli,et al.  miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells , 2021, Non-coding RNA.

[43]  Zhibin Hu,et al.  SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response , 2021, Journal of biomedical research.

[44]  Yaogang Wang,et al.  Association analysis framework of genetic and exposure risks for COVID-19 in middle-aged and elderly adults , 2021, Mechanisms of Ageing and Development.

[45]  T. Welte,et al.  Circulating cardiovascular microRNAs in critically ill COVID‐19 patients , 2021, European journal of heart failure.

[46]  R. Kapila,et al.  Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint , 2020, Virus Research.

[47]  J. Roganović.  Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19 , 2020, Medical Hypotheses.

[48]  OUP accepted manuscript , 2021, Cardiovascular Research.

[49]  S. Rezaee,et al.  Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities , 2020, Journal of Oral Biology and Craniofacial Research.

[50]  J. Roganović.  microRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptors genes. , 2020, Journal of periodontology.

[51]  S. Ramakrishna,et al.  MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti‐COVID‐19 Therapeutics , 2020, Frontiers in Pharmacology.

[52]  H. Akhavan-Niaki,et al.  Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations , 2020, Gene Reports.

[53]  L. Cavalli,et al.  Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients , 2020, American journal of physiology. Lung cellular and molecular physiology.

[54]  A. Dursun,et al.  A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID‐19 progression , 2020, International journal of immunogenetics.

[55]  Maryam Moazzam Jazi,et al.  High affinity of host human microRNAs to SARS-CoV-2 genome: An in silico analysis , 2020, Non-coding RNA Research.

[56]  I. Bozgeyik.  Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2 , 2020, Meta Gene.

[57]  K. Kang,et al.  Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2 , 2020, Molecules and cells.

[58]  Viorel Simion,et al.  Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs , 2020, Genes.

[59]  G. Santulli,et al.  miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19 , 2020, Biomedicines.

[60]  M. Tumminello,et al.  miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA , 2020, Frontiers in Cellular and Infection Microbiology.

[61]  D. Gupta,et al.  Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis , 2020, Frontiers in Genetics.

[62]  Yingfeng Zheng,et al.  The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID‐19 , 2020, Clinical and translational medicine.

[63]  Caixia Li,et al.  Differential microRNA expression in the peripheral blood from human patients with COVID‐19 , 2020, Journal of clinical laboratory analysis.

[64]  A. Tonevitsky,et al.  Potential role of cellular miRNAs in coronavirus-host interplay , 2020, PeerJ.

[65]  Yibin Wang,et al.  MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes , 2020, Journal of Molecular and Cellular Cardiology.

[66]  Prithvi Singh,et al.  Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19) , 2020, Gene.

[67]  L. Salmena,et al.  Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium , 2020, Genes.

[68]  Samira Mahmoudi,et al.  Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors , 2020, Informatics in Medicine Unlocked.

[69]  Abhijit Sarma,et al.  An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2 , 2020, Computational Biology and Chemistry.

[70]  A. Tonevitsky,et al.  Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2 , 2020, PloS one.

[71]  Michael D Healy,et al.  SARS-CoV-2 viral load is associated with increased disease severity and mortality , 2020, Nature Communications.

[72]  M. Ferracin,et al.  Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients , 2020, Mechanisms of Ageing and Development.

[73]  G. Ciliberto,et al.  TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients , 2020, Journal of Experimental & Clinical Cancer Research.

[74]  G. Grant,et al.  The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities , 2020, Viruses.

[75]  Paweł P. Łabaj,et al.  Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions , 2020, Cytokine.

[76]  Rodrigo Pavão,et al.  ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors , 2020, bioRxiv.

[77]  Md. Abdullah-Al-Kamran Khan,et al.  Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19 , 2020, bioRxiv.

[78]  B. Sahay,et al.  COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile , 2020, Aging and disease.

[79]  S. Nersisyan,et al.  Role of ACE2/TMPRSS2 genes regulation by intestinal microRNA isoforms in the COVID-19 pathogenesis , 2020 .

[80]  L. Boppana,et al.  An update on the 2019-nCoV outbreak , 2020, American Journal of Infection Control.

[81]  M. Pal,et al.  Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update , 2020, Cureus.

[82]  Ralph S. Baric,et al.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.

[83]  M. Romans.  Altered , 2019 .

[84]  Vijay Kotu,et al.  Association Analysis , 2019, Data Science.

[85]  I. Amiri,et al.  The Role of microRNAs in the Viral Infections. , 2019, Current pharmaceutical design.

[86]  M. Hoffmann,et al.  Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins , 2018, Activation of Viruses by Host Proteases.

[87]  Silvia Bottini,et al.  Viruses and miRNAs: More Friends than Foes , 2017, Front. Microbiol..

[88]  William B. Klimstra,et al.  MicroRNA Regulation of RNA Virus Replication and Pathogenesis , 2016, Trends in Molecular Medicine.

[89]  Leigh-Ann MacFarlane,et al.  MicroRNA: Biogenesis, Function and Role in Cancer , 2010, Current genomics.